Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Zhitong Biopharmaceutical is a China-based pharmaceutical manufacturer focused on the research, production, and commercialization of biochemical and chemical drugs, with a particular emphasis on polypeptide-derived products. The company operates from Baoding, Hebei, and markets a broad portfolio of approved products across neurology, musculoskeletal, respiratory, digestive, cardiovascular, vitamin, and anti-infective categories. Zhitong highlights four internal technology platforms spanning polypeptide drugs and nutrition, liquid hard capsules, ergot alkaloids, and chemical drug industrialization. Its visible product portfolio appears centered on commercialized hospital and prescription products such as compound bone peptide injection and cerebroprotein hydrolysate injection rather than a venture-style innovative clinical pipeline. The company also reports subsidiaries involved in pharmaceutical manufacturing and sales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Zhitong Biopharmaceutical.